What is the role for surgery in patients with stage III non-small cell lung cancer?

Current Opinion in Pulmonary Medicine

Volumn 15, Issue 4, 2009, Pages 295-302

  Vandenbroucke, Elke ^a   De Ryck, Frederic ^a   Surmont, Veerle ^a   Van Meerbeeck, Jan P ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chemoradiotherapy; Combined modality; Non small cell lung cancer; Stage III; Surgery

Indexed keywords

CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; MITOMYCIN; NAVELBINE; PACLITAXEL; VINBLASTINE; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PROGRESSION FREE SURVIVAL; REVIEW; SURVIVAL RATE; SURVIVAL TIME; THORACOTOMY; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING;

EID: 67449096300     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32832cbefc     Document Type: Review

References (38)

1. Molina JR, Yang P, Cassivi SD, et al. Nonsmall cell lung cancer: epidemiology, risk factors, treatment and survivorship. Mayo Clin Proc 2008; 83:584-594.
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717. (Pubitemid 27260107)
3. Goldstraw P, Crowley JJ, Chansky K, et al. On behalf of the international Association for the Study of Lung Cancer International Staging Committee and Participating Institutions. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumors. J Thor Oncol 2007; 2:705-714.
4. Shaw RR, Paulson DL, Kee JL Jr. Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 1961; 154:29-40.
5. Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for superior sulcus nonsmall cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 2007; 25:313-318. (Pubitemid 350003020)
6. Kunitoh H, Kato H, Tsuboi M, et al. Phase II trial of preoperative chemor•• adiotherapy followed by surgical resection in patients with superior sulcus nonsmall cell lung cancers: report of Japan Clinical Oncology Group Trial 9806. J Clin Oncol 2008; 26:644-649. Phase 2 trial confirming impressive survival rates for SST after complete resection following chemoradiation but without adjuvant chemotherapy. (Pubitemid 351264361)
7. Marra A, Eberhardt W, Pöttgen C, et al. Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour. Eur Resp J 2007; 29:117-127. (Pubitemid 46092007)
8. Pourel N, Santelmo N, Naafa N, et al. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III nonsmall cell lung cancer yields a high rate of pathological complete response. Eur J Cardiothorac Surg 2008; 13:829-836.
9. Yildizeli B, Dartevelle PG, Fadel E, et al. Results of primary surgery with T4 nonsmall cell lung cancer during a 25-year period in a single centre: the benefit is worth the risk. Ann Thorac Surg 2008; 86:1065-1075.
10. De Leyn P, Vansteenkiste J, Lievens Y, et al. Survival after trimodality treatment for superior sulcus and central T4 nonsmall cell lung cancer. J Thorac Oncol 2009; 4:62-68.
11. Misthos P, Papagiannakis G, Kokotsakis J, et al. Surgical management of lung cancer invading the aorta or the superior vena cava. Lung Cancer 2007; 56:223-227. (Pubitemid 46590488)
12. Farjah F, Wood DE, Varghese TK, et al. Trends in the operative management and outcomes of T4 lung cancer. Ann Thorac Surg 2008; 86:368-375. (Pubitemid 351978052)
13. Wu L, Xu Z, Zhao X, et al. Surgical treatment of lung cancer invading the left atrium of base of the pulmonary vein. World J Surg 2009; 33:492-496. doi: 10/1007/s00268-008-9873-9875
14. Anraku M, Waddell TK, de Perrot M, et al. Induction chemoradiotherapy facilitates radical resection of T4 nonsmall cell lung cancer invading the spine. J Thorac Cardiovasc Surg 2009; 137:441-447.
15. Port JL, Korst RJ, Lee PC, et al. Surgical resection for multifocal (T4) nonsmall cell lung cancer: is the T4 designation valid? Ann Thorac Surg 2007; 83:397-401.
16. Trousse D, D'Journo XD, Avaro JP. Multifocal T4 nonsmall cell lung cancer: a subset with improved prognosis. Eur J Cardiothorac Surg 2008; 33:99-103. (Pubitemid 350266350)
17. Rao J, Sayeed RA, Tomaszek S, et al. Prognostic factors in resected satellite-nodule T4 nonsmall cell lung cancer. Ann Thorac Surg 2007; 84:934-939. (Pubitemid 47285051)
18. Shen KR, Meyers BF, Larner JM, Jones DR. Special treatment issues in lung cancer: ACCP guidelines evidence-base clinical practice guidelines (2nd ed.). Chest 2007; 132:290S-305S. (Pubitemid 47494409)
19. Jett JR, Schild SE, Keith RL, et al. Treatment of nonsmall cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd ed.). Chest 2007; 132:266S-276S.
20. Robinson LA, Ruckdeschel JC, Wagner H, et al. Treatment of nonsmall cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd ed.). Chest 2007; 132:243-265.
21. D'Addaria G, Felip E. Nonsmall-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19 (Suppl): ii39-ii40.
22. NCCN Clinical Practice Guidelines in Oncology. Nonsmall cell lung cancer. V.2.2009. www.nccn.org.
23. Garrido P, Gonzales-Iarriba JL, Insa A, et al. Long term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) nonsmall cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. J Clin Oncol 2007; 25:4736-4742. (Pubitemid 350086475)
24. Van Meerbeeck JP, Kramer GW, Van Schil PE, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 nonsmall cell lung cancer. J Natl Cancer Inst 2007; 99:442-450. (Pubitemid 47073567)
25. Thomas M, Rübe C, Hoffknecht P, et al. Effect of preoperative chemoradiation • in addition to preoperative chemotherapy: a randomized trial in stage III nonsmall cell lung cancer. Lancet Oncol 2008; 9:636-648. This trial shows that after more intensive induction regimen, mediastinal downstaging and tumor regression does not lead to a better patient outcome.
26. Gottfried M, Ramlou R, Krzakowski M, et al. Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced nonsmall cell lung cancer. Final results. J Thorac Oncol 2008; 3:152-157. (Pubitemid 351323190)
27. Uy KL, Darling GD, Xu W, et al. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 nonsmall cell lung cancer. J Thorac Cardiovasc Surg 2007; 134:188-193. (Pubitemid 46962027)
28. Mansour Z, Kochetkova EA, Santelmo N, et al. Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy. Ann Thorac Surg 2008; 86:228-233.
29. Carretta A, Ciriaco P, Melloni G, et al. Results of surgical treatment after neoadjuvant chemotherapy for stage III nonsmall cell lung cancer. World J Wurg 2008; 32:2636-2642.
30. Yap S-P, Lim W-T, Foo K-F, et al. Induction concurrent chemoradiotherapy using paolitaxel and carboplatin combination followed by surgery in locoregionally advanced nonsmall cell lung cancer: Asian experience. Ann Acad Med Singapore 2008; 37:377-382.
31. Albein KS, Swann RS, Rusch VR, et al. Phase III study of concurrent chemoradiotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) nonsmall cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 (RTOG 9309) [abstract]. J Clin Oncol 2005; 23:7014.
32. Van Schil P, Van Meerbeeck J, Kramer G, et al. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur Resp J 2005; 26:192-197. (Pubitemid 41079061)
33. Belani CP, Wang W, Johnson DH, et al. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy of hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B nonsmall cell lung cancer. J Clin Oncol 2005; 23:3760-3767. (Pubitemid 46252472)
34. Girard N, Mornex F. Therapeutic strategies in superior sulcus tumors: a model for combined modality therapy in nonsmall cell lung cancer. Cancer/radiothérapie 2007; 11:59-66. (Pubitemid 46533947)
35. Dartevelle PG, Chapelier AR, Macchiarini P, et al. Anterior transcervicalthoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 1993; 105:1025-1034. (Pubitemid 23178833)
36. Grunenwald D, Spaggiari L. Transmanubrial osteomuscular sparing approach for apical chest tumors. Ann Thorac Surg 1997; 63:563-566. (Pubitemid 27084604)
37. Scandinavian Neoadjuvant Phase III Study of Induction Chemotherapy Followed by Irradiation Alone or Surgery Plus Irradiation in NSCLC Stage IIIA/N2 (T1N2, T2N2, T3/N2). NCT00273494. Bethesda, MD: National Library of Medicine; 2009. http://www.clinicaltrials.gov. [Accessed 5 February 2009].
38. Preoperative Chemoradiotherapy Vs. Chemotherapy Alone In Non-Small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2): A Randomized Prospective Phase III Trial. NCT00030771. Bethesda, MD: National Library of Medicine; 2009. http://www.clinicaltrials.gov. [Accessed 5 February 2009]